8090 Partners is a multi-family office that employs a three-pronged investment strategy: Growth Equity for promising growth-stage technology companies, a Thematic Fund for high-conviction early-stage technology investments, and Special Situations for opportunistic capital in venture-backed technology firms. The firm focuses on direct and opportunistic investments, collaborating with industry-leading families and entrepreneurs.
50% of their portfolio is in Healthcare. Their most common stage is growth (50% of deals). Average disclosed round size is $230.7M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nitra | Seed | $62M | Aug 2022 |
 Cera Care | Growth | $310M | Aug 2022 |
 Cera | Growth | $320M | Aug 2022 |
 Cemvita Factory | Series A | — | Aug 2021 |
Top Co-Investors
Jane Street Capital2 shared
Schroders Capital2 shared
Yabeo2 shared
Squarepoint Capital2 shared
Guinness Ventures2 shared
Oltre Impact2 shared
Andreessen Horowitz1 shared
NEA (New Enterprise Associates)1 shared
Pantera1 shared
KB Partners1 shared
AME Cloud1 shared
Dreamers VC1 shared
CoVenture1 shared
Primer Sazze1 shared
Dunamu1 shared
Expa1 shared
Soma Capital1 shared
Slope1 shared
K50 Ventures1 shared
Gaingels1 shared
Last updated: 16 April 2026